1. Home
  2. AGNC vs GKOS Comparison

AGNC vs GKOS Comparison

Compare AGNC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGNC Investment Corp.

AGNC

AGNC Investment Corp.

HOLD

Current Price

$10.81

Market Cap

10.7B

Sector

Real Estate

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$115.52

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGNC
GKOS
Founded
2008
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
5.4B
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
AGNC
GKOS
Price
$10.81
$115.52
Analyst Decision
Buy
Strong Buy
Analyst Count
10
13
Target Price
$10.34
$126.38
AVG Volume (30 Days)
16.2M
694.2K
Earning Date
01-26-2026
10-29-2025
Dividend Yield
13.27%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$956,000,000.00
$469,820,000.00
Revenue This Year
$8.02
$31.15
Revenue Next Year
$65.46
$24.15
P/E Ratio
$15.41
N/A
Revenue Growth
N/A
30.38
52 Week Low
$7.85
$73.16
52 Week High
$10.93
$163.71

Technical Indicators

Market Signals
Indicator
AGNC
GKOS
Relative Strength Index (RSI) 64.32 70.14
Support Level $10.28 $115.07
Resistance Level $10.93 $117.94
Average True Range (ATR) 0.15 2.86
MACD 0.03 -0.28
Stochastic Oscillator 80.92 77.46

Price Performance

Historical Comparison
AGNC
GKOS

About AGNC AGNC Investment Corp.

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: